Exploring Advancements in Modelling Neurobiology with Human iPSC-derived Cells

One of the biggest challenges facing CNS scientists today is the need for in vitro cell models that accurately represent the complexity of human diseases. In this workshop, you will hear from neuroscience experts as they share their practical experiences in using human iPSC-derived cells to effectively model neurodegeneration, neuroimmunology, and neurodevelopment. Explore innovative approaches used to replicate complex cell interactions and investigate disease phenotypes in vitro.
 
You will also have the opportunity to engage in an interactive roundtable discussion with the speakers to learn more about the implementation of human iPSC-derived cells, unique methods for tackling reproducibility and promising technologies in the stem cell field.
 
In addition, there will be several opportunities to network with scientists working in academia and industry over tea, coffee and pastries.

Agenda: 

• 08:45 - 9:00am - Refreshments & registration
• 09:00 - 09:05 - Welcome 
  Dr Davide Danovi, bit.bio
• 09:05 – 09:30 – Modelling HSV1 infection in patient derived cerebral organoids 
  Dr Vanessa Sancho Shimizu, Imperial College London
• 09:30 – 09:55 – Using human iPSC-derived microglia to study genetic and environmental influences on microglia form and function 
  Dr Tony Vernon, King’s College London
• 10:00 – 10:45 - Break and networking 
• 10:45- 11:10 – Modelling rare human diseases using iPSCs - potentials and challenges 
  Professor Patrizia Ferretti, University College London
• 11:10 - 11:35   - Using human iPSC-derived cells to study the neurobiology of ZNF804A – the original schizophrenia common variant
  Prof. Deepak Srivastava, King’s College London
• 11:35 - 12:00  – Precision Cellular Reprogramming for Scalable and Consistent Generation of Human Neurodegenerative Disease Models 
  Madeleine Garrett, bit.bio
• 12:00 - 12:45 - Roundtable discussion: Advancing Translational Research | Human iPSC-derived cells as a promising tool for studying neurological disorders 
  Moderated by Dr Davide Danovi, bit.bio
• 12:45 - 12.50 Closing remarks
  Dr Davide Danovi, bit.bio